NF- kappa B activating gene
AssigneeAsahi Kasei Pharma Corporation
InventorsAkio Matsuda, Goichi Honda, Shuji Muramatsu, Yukiko Nagano
Life of this patent
Estimating the term…
Loading patent…
AssigneeAsahi Kasei Pharma Corporation
InventorsAkio Matsuda, Goichi Honda, Shuji Muramatsu, Yukiko Nagano
Estimating the term…
Provided are proteins having NF-κ B activity, which are used for diagnosing, treating or preventing diseases associated with the excessive activation or inhibition of NF-κ B. Using plasmid pNFκ B-Luc, cDNA encoding a protein capable of activating NF-κ B has been cloned from a cDNA library constructed from human lung fibroblasts, and the DNA sequence and the deduced amino acid sequence determined. The protein, the DNA encoding the protein, a recombinant vector containing the DNA, and a transformant containing the recombinant vector are useful for screening a substance inhibiting or promoting NF-κ B activation.
A purified protein selected from the group consisting of:
An isolated polynucleotide which comprises a nucleotide sequence encoding a protein selected from the group consisting of:
An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of:
An isolated polynucleotide comprising a polynucleotide sequence selected from the group consisting of:
A method for screening compounds in respect of activity to inhibit or promote NF-κ B activation, which comprises the steps of:
A process for producing a pharmaceutical composition, which comprises the steps of:
A kit for screening a compound in respect of activity to inhibit or promote NF-κ B activation, which comprises:
A double stranded nucleic acid obtained by annealing of any one of the following oligonucleotide pairs (a)-(f):
A method for obtaining a novel gene having a function, which comprises at least the following steps:
A computer-readable medium on which a sequence data set has been stored, said sequence data set comprising at least one nucleotide sequence selected from the group consisting of SEQ ID NOS:
An insoluble substrate to which polynucleotides comprising all or part of the nucleotide sequences selected from the group consisting of SEQ ID NOS:
An insoluble substrate to which polypeptides comprising all or a part of the amino acid sequences selected from the group consisting of SEQ ID NOS:
Dependencies are inferred from the claim text.